Synthetic studies toward the development of novel minoxidil analogs and conjugates with polyamines

Tetrahedron Letters

Volumn 51, Issue 15, 2010, Pages 1989-1993

  Magoulas, George E ^a   Bariamis, Stavros E ^a   Athanassopoulos, Constantinos M ^a   Papaioannou, Dionissios ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Minoxidil; N,N Carbonyldiimidazole; N Oxides; Nucleophilic aromatic substitution; Polyamine conjugates; Pyrimidines

Indexed keywords

MINOXIDIL; MINOXIDIL DERIVATIVE; POLYAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG CONJUGATION; DRUG SELECTIVITY; DRUG SOLUBILITY; DRUG SYNTHESIS;

EID: 77649275279     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2010.02.037     Document Type: Article

References (46)

1. Messenger A.G., and Rundegren J. Βr. J. Dermatol. 150 (2004) 186 and references cited therein
2. Johnson G.A., Barsuhn K.J., and McCall J.M. Biochem. Pharmacol. 31 (1982) 2949
3. Meisheri K.D., Johnson G.A., and Puddington L. Biochem. Pharmacol. 45 (1993) 271
4. Anderson R.J., Kudlacek P.E., and Clemens D.L. Chem. Biol. Interact. 109 (1998) 53
5. Meisheri K.D., Cipkus L.A., and Taylor C.J. J. Pharmacol. Exp. Ther. 245 (1988) 751
6. Winquist R.J., Heaney L.A., Wallace A.A., Baskin E.P., Stein R.B., Garcia M.L., and Kaczorowsk G.J. J. Pharmacol. Exp. Ther. 248 (1989) 149
7. Mannhold R. Med. Res. Rev. 24 (2004) 213 and references cited therein
8. Kurata S., Uno H., and Allen-Hoffmann L. Skin Pharmacol. Physiol. 9 (1996) 3
9. Ellis J.A., and Sinclair R.D. Drug Discovery Today 13 (2008) 791
10. For reviews on polyamine-conjugates see:. Blagbrough I.S., Carrington S., and Geall A. J. Pharm. Sci. 3 (1997) 223
11. Schulz S. Angew. Chem., Int. Ed. Engl. 36 (1997) 314
12. Karigiannis G., and Papaioannou D. Eur. J. Org. Chem. (2000) 1841
13. Kuksa V., Buchan R., and Kong Thoo Lin P. Synthesis (2000) 1189
14. Hahn F., and Schepers U. Top. Curr. Chem. 278 (2007) 135
15. For some recent examples of medicinally interesting polyamine-conjugates see:. Camps P., Formosa X., Muñoz-Torrero D., Petrignet J., Badia A., and Clos M.V. J. Med. Chem. 48 (2005) 1701
16. Cholody W.M., Kosakowska-Cholody T., Hollingshead M.G., Hariprakasha H.K., and Michejda C.J. J. Med. Chem. 48 (2005) 4474
17. Nagarajan M., Morrell A., Antony S., Kohlhagen G., Agama K., Pommier Y., Ragazzon P.A., Garbett N.C., Chaires J.B., Hollingshead M., and Cushman M. J. Med. Chem. 49 (2006) 5129
18. Oves D., Fernández S., Verlinden L., Bouillon R., Verstuyf A., Ferrero M., and Gotor V. Bioorg. Med. Chem. 14 (2006) 7512
19. Battaglia A., Guerrini A., Baldelli E., Fontana G., Varchi G., Samori C., and Bombardelli E. Tetrahedron Lett. 47 (2006) 2667
20. Wu D., Ji S., Wu Y., Ju Y., and Zhao Y. Bioorg. Med. Chem. Lett. 17 (2007) 2983
21. Magoulas G., Papaioannou D., Papadimou E., and Drainas D. Eur. J. Med. Chem. 44 (2009) 2689
22. Recently, solubility studies of minoxidil in water in the form of inclusion complexes with β-CD have been described in:. Calderini A., and Pessine F.B.T. J. Incl. Phemon. Macrocycl. Chem. 60 (2008) 369
23. Olsen E.A., Whiting D., Bergfeld W., Miller J., Hordinsky M., Wanser R., Zhang P., and Kohut B. J. Am. Acad. Dermatol. 57 (2007) 767
24. For selected examples of other minoxidil derivatives, their synthesis and mode of action, see:. McCall J.M., Aiken J.W., Chidester C.G., DuCharme D.W., and Wendling M.G. J. Med. Chem. 26 (1983) 1791
25. Hengartner U., Muller J.-C., and Ramuz H. Helv. Chim. Acta 66 (1983) 669
26. Muller J.-C., Ramuz H., and Wagner H.P. Helv. Chim. Acta 66 (1983) 809
27. Murad S., Tennant M.C., and Pinnell S.R. Arch. Biochem. Biophys. 292 (1992) 234
28. Singer S.S. Chem. Biol. Interact. 92 (1994) 33
29. Part of this work was presented in the form of a poster at the 10th Tetrahedron Symposium, Paris, 2009, Abstract Book (P C132).
30. Krapcho A.P., and Kuell C.S. Synth. Commun. 20 (1990) 2559
31. The preparation, in only 31% yield (see however Supplementary data), and the characterization of 2 was subsequently described in:. Vassis S., Govaris I., Voyatzi K., Mamos P., and Papaioannou D. Tetrahedron Lett. 43 (2002) 2597
32. McCarthy O., Musso-Buendia A., Kaiser M., Brun R., Ruiz-Perez L.M., Gunnar Johansson N., Gonzalez Pacanowska D., and Gilbert I.H. Eur. J. Med. Chem. 44 (2009) 678
33. Geall A.J., and Blagbrough I.S. Tetrahedron 56 (2000) 2449
34. The preparation of this compound (see Supplementary data) initially required selective protection of the primary amino functions using the trifluoroacetyl group as described in:. O'Sullivan M.C., and Dalrymple D.M. Tetrahedron Lett. 36 (1995) 3451
35. Averin A.D., Ulanovskaya O.A., and Beletskaya I.P. Chem. Heterocycl. Compd. 44 (2008) 1146
36. McCall J.M., TenBrink R.E., and Ursprung J.J. J. Org. Chem. 40 (1975) 3304
37. Jovanovic M.V. Can. J. Chem. 62 (1984) 1176
38. Kress T.J. J. Org. Chem. 50 (1985) 3073
39. Allaigre, J. P.; Desbois, J. FR. Patent 2,632,954, 1989; Chem. Abstr. 1989, 113, 212009.
40. Yamanaka H., Sakamoto T., and Niitsuma S. Heterocycles 31 (1990) 923
41. Rhie S.Y., and Ryu E.K. Heterocycles 41 (1995) 323
42. Mlakar B., Stefane B., Kocevar M., and Polanc S. Tetrahedron 54 (1998) 4387
43. Buscemi S., Pace A., Piccionello A.P., Vivona N., and Pani M. Tetrahedron 62 (2006) 1158
44. Muller J.-C., and Ramuz H. Helv. Chim. Acta 65 (1982) 1445 and references cited therein
45. Muller J.-C., Ramuz H., Daly J., and Schonholzer P. Helv. Chim. Acta 65 (1982) 1454
46. Seiler N. Pharmacol. Ther. 107 (2005) 99